This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) rose 7.81% to $455.92 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.25% to 15,248.25 and Dow Jones Industrial Average falling 0.43% to 34,879.38. Moderna Inc. closed $41.57 short of its 52-week high ($497.49), which the company achieved on August 10th.
The stock outperformed some of its competitors Thursday, as AbbVie Inc. (ABBV) fell 2.80% to $107.27, Amgen Inc. (AMGN) fell 2.40% to $215.58, and AstraZeneca PLC ADR (AZN.LN) fell 1.37% to $56.29. Trading volume (22.1 M) eclipsed its 50-day average volume of 19.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 9, 2021.
(END) Dow Jones Newswires
September 09, 2021 16:31 ET (20:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.